Intelligence · Clinical Development
Pipeline search results
Programs matching “dexamethasone” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 46 pipeline programs matching "dexamethasone" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Dexamethasone
The First People's Hospital of Lianyungang
Precursor B-Cell Lymphoblastic Leukemia
1 trial -
Dexamethasone Combined with romiplostim N01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Immune Thrombocytopenia
1 trial -
IST-342
Karyopharm Therapeutics Inc
Relapsed Multiple Myeloma
1 trial -
Ixazomib/Pomalidomide/Dexamethasone
Takeda
Multiple Myeloma
1 trial -
MyDRUG (MMRC-085)
Karyopharm Therapeutics Inc
Relapsed Refractory Multiple Myeloma
1 trial -
bortezomib/dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acquired Pure Red Cell Aplasia
1 trial -
rituximab /Dexamethasone/cyclophosphamide
The First People's Hospital of Lianyungang
Treatment
1 trial -
ΕΑΕ-2018/ΜΜ03
Takeda
Multiple Myeloma
1 trial -
Dexamethasone
NEUROCRINE BIOSCIENCES INC
Healthy
1 trial -
EryDex (dexamethasone sodium phosphate encapsulated erythrocytes)
Quince Therapeutics
Healthy
1 trial -
HQP1351ACE01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lymphoblastic Leukemia, Acute, Childhood
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Dexamethasone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Localized Primary Osteoarthritis of Both Hips (Diagnosis)
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Carcinoma, Non-Small-Cell Lung
1 trial -
Dexamethasone
The University of Hong Kong
Total Knee Replacement
1 trial -
Dexamethasone and N-acetylcysteine (NAC)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carbon Monoxide Poisoning
1 trial -
Dexamethasone and N-acetylcysteine (NAC)
Hospital Authority, Hong Kong
Carbon Monoxide Poisoning
1 trial -
Dexamethasone tablets for Solid tumors
Disc Medicine
Solid tumors
1 trial -
Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
SHCZH-2010-CT-001
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Cataract
1 trial -
Subconjunctival dexamethasone and general anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.